Increased sarcolemmal glucose transporter, abundance in myocardial ischemia

American Journal of Cardiology

Volumn 80, Issue 3 A, 1997, Pages 77A-84A

  Brosius III, Frank C ^a   Nguyen, Ngoc ^b   Egert, Silvia ^b   Lin, Zhiwu ^a   Deeb, G Michael ^a   Haas, F ^c   Schwaiger, Markus ^b   Sun, Daqing ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC HEART DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOLEMMA;

EID: 0030813376     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00460-8     Document Type: Conference Paper

References (48)

1. Liedtke A. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 23:1981;321-336.
2. Opie LH, Camici PG. Myocardial blood flow, deoxyglucose uptake and myocyte viability in ischemia. J Nucl Med. 33:1992;1353-1356.
3. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res. 66:1990;344-354.
4. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 68:1991;466-481.
5. Schwaiger M, Neese RA, Araujo L, Wyns W, Wisneski JA, Sochor H, Swank S, Kulber D, Selin C, Phelps M, Schelbert HR, Fishbein MC. Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium. J Am Coll Cardiol. 13:1989;745-754.
6. 18F-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 67:1983;766-778.
7. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelbert H. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 314:1986;884-888.
8. vom Dahl J, Eitzman DT, Al-Aouar ZR, Kanter HL, Hicks RJ, Deeb GM, Kirsh MM, Schwaiger M. Relation of regional function, perfusion and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation. 90:1994;2356-2366.
9. Sodi-Pallares D, Testelli MR, Fishleder BL, Bistni A, Medrano GA, Friedland C, De Micheli A. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol. 9:1962;166-181.
10. Mantle JA, Rogers WJ, Smith R, McDaniel HG, Papapietro SE, Russel RO Jr., Rackley CE. Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. Am Heart J. 102:1981;313-324.
11. Rogers WJ, Stanley AW Jr, Breinig JB, Prather JW, McDaniel HG, Moraski RE, Mantle JA, Russell RO Jr, Rackley CE. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J. 92:1976;441-454.
12. Malmberg K, Ryden L, Effendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 26:1995;57-65.
13. Coleman GM, Gradinac S, Taegtmeyer H, Sweeney M, Frazier OH. Efficacy of metabolic support with glucose-insulin-postassium for left ventricular pump failure after aortocoronary bypass surgery. Circulation. 80:((suppl I)):1989;I-91-I-96.
14. King LM, Boucher F, Opie LH. Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardium. J Mol Cell Cardiol. 27:1995;701-720.
15. DeLeiris J, Opie LH, Lubbe WF. Effects of free fatty acid and glucose on enzyme release in experimental myocardial infarction. Nature. 253:1975;746-747.
16. Wheeler TJ. Translocation of glucose transporters in response to anoxia in heart. J Biol Chem. 263:1988;19447-19454.
17. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ, James DE. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem J. 295:1994;287-293.
18. Kahn BB. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest. 89:1992;1367-1374.
19. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA. 88:1991;7815-7819.
20. Doria-Medina CL, Lund DD, Pasley A, Sandra A, Sivitz WI. Immunolocalization of GLUT-1 glucose transporter in rat skeletal muscle and in normal and hypoxic cardiac tissue. Am J Physiol. 265:1993;E454-E464.
21. Sun DQ, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC III. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation. 89:1994;793-798.
22. Zaninetti D, Greco-Perotto R, Assimacopoulos-Jeannet F, Jeanrenaud B. Effects of insulin on glucose transporters in rat heart. Biochem J. 250:1988;277-283.
23. Marcus RG, England R, Nguyen K, Charron MJ, Briggs JP, Brosius FC III. Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus. Am J Physiol. 267:1994;F816-F824.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
25. Chen M, Schnermann J, Smart AM, Brosius FC III, Killen PD, Briggs JP. Cyclic AMP selectively increases renin mRNA stability in cultured juxtaglomerular granular cells. J Biol Chem. 268:1993;24138-24144.
26. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF. Sequence and structure of a human glucose transporter. Science. 229:1985;941-945.
27. Fukumoto H, Kayano T, Buse JB, Edwards Y, Pilch PF, Bell GI, Seino S. Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem. 264:1989;7776-7779.
28. Haendler B, Hofer-Warbinek R, Hofer E. Complementary DNA for human T-cell cyclophilin. EMBO J. 6:1987;947-950.
29. Sabath DE, Broome HE, Prystowsky MB. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 91:1990;185-191.
30. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L. Isolation and characterization of full-length cDNA clones for human α -, β -, and γ -actin mRNAs: Skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol. 3:1983;787-795.
31. Higuchi R. Recombinant PCR. Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR protocols: A Guide to Methods and Applications. 1990;177-183 Academic Press, San Diego.
32. Charron MJ, Brosius FC III, Alper SL, Lodish HF. A novel glucose transport protein expressed predominately in insulin-sensitive tissues. Proc Natl Acad Sci USA. 86:1989;2535-2539.
33. Birnbaum MJ, Haspel HC, Rosen OM. Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci USA. 83:1986;5784-5788.
34. Sadoshima JI, Jahn L, Takahash T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. J Biol Chem. 267:1992;10551-10560.
35. Santalucia T, Camps M, Castello A, Munoz P, Nuel A, Testar X, Palacin M, Zorzano A. Developmental regulation of GLUT1 (Erythroid/HepG2) and GLUT4 (Muscle/Fat) glucose transporter expression in rat heart, skeletal muscle and brown adipose tissue. Endocrinology. 130:1992;837-846.
36. Brosius FC III, Liu Y, Nguyen N, Sun DQ, Bartlett J, Schwaiger M. Persistent myocardial ischemia increases GLUT1 glucose transporter expression in both ischemic and non-ischemic heart regions. (in press). J Mol Cell Cardiol. 29:1997.
37. Mallet RT, Hartman DA, Bunger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem. 188:1990;481-493.
38. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res. 69:1991;571-581.
39. Billman G. Role of ATP sensitive potassium channels in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res. 28:1994;762-769.
40. + channels involves high-energy phosphate preservation. Am J Physiol. 265:1993;H1809-H1818.
41. Wolleben CD, Sanguinetti MC, Siegl PKS. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol. 21:1989;783-788.
42. Tosaki A, Szerdahelyi P, Engelman RM, Das DK. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J Pharm Exp Ther. 267:1993;1355-1362.
43. + channels in isolated guinea pig cardiac myocytes. Science. 238:1987;67-69.
44. O'Rourke B, Ramza BM, Marban E. Oscillations of membrane current and excitability driven by metabolic oscillation in heart cells. Science. 265:1994;962-996.
45. Berger J, Hayes N, Szalkowski DM, Zhang B. PI 3-kinase activation is required for insulin stimulation of glucose transport into L6 myocytes. Biochem Biophys Res Commun. 205:1994;570-576.
46. Clarke JF, Young PW, Yonezawa K, Kasuga M, Holman GD. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J. 300:1994;631-635.
47. Kanai F, Ito K, Todaka M, Hayashi H, Kamohara S, Ishii K, Okada T, Hazeki O, Ui M, Ebina Y. Insulin-stimulated GLUT4 translocation is relevant to the activity of PI 3-kinase. Biochem Biophys Res Commun. 195:1993;762-768.
48. Taha C, Klip A. Role of p38 and MAPK in the stress-mediated induction of GLUT1 and GLUT3 glucose transporters. (Abstr.) Diabetes. 45:1996;184A.